Investors / United Kingdom / Cambridge Innovation Capital
Cambridge Innovation Capital
Venture capital · Cambridge, United Kingdom · Europe
Cambridge Innovation Capital is a venture investor in the Cambridge ecosystem, backed by a proprietary agreement with the University of Cambridge. It provides financial backing and guidance to knowledge-intensive businesses in life sciences and deep tech.
Invests inHealthcare & Biotech
In its own wordslife sciencesdeep techcancer diagnosticssemiconductorsquantum computingesg
Your fit with Cambridge Innovation Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsCambridge Innovation Capital lists 49 checked portfolio companies on its own site and is named in 9 funding rounds, 3 of them as lead. Its most frequent entry is Seed, 38% of the companies with a known first round. Its largest themes are Healthcare & Biotech (62%), AI & Machine Learning (12%) and Industrial & Manufacturing (8%). 71% of its companies are based in United Kingdom. It invests most often alongside Amadeus Capital Partners, BGF and Advent Life Sciences.
Counts come from funding rounds that name Cambridge Innovation Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Cambridge Innovation Capital's whole history. Rounds on record name 9 companies; its own site lists 49. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 38% |
| Series A | 25% |
| Series B | 13% |
| Growth | 25% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 3 | 1 |
| '26 | 6 | 2 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 83th | 49 companies |
| Recent activity | 89th | 6 rounds in 12 months |
| Early stage | 65th | 38% of entries at pre-seed or seed |
| Evidence | 85th | 14% of companies confirmed by a round |
| Sector focus | 89th | 62% in its largest sector |
| Reach | 84th | 6 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 62% | 15% |
| AI & Machine Learning | 12% | 18% |
| Industrial & Manufacturing | 8% | 7% |
| Fintech | 5% | 12% |
| Enterprise Software | 5% | 8% |
| Cybersecurity | 3% | 4% |
| Consumer | 3% | 3% |
| Media & Entertainment | 2% | 4% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Amadeus Capital Partners | 4 |
| BGF | 4 |
| Advent Life Sciences | 3 |
| British Business Bank | 3 |
| ARCH Venture Partners | 2 |
| F-Prime Capital | 2 |
| Future Planet Capital | 2 |
| Octopus Ventures | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers4796%
- No longer answers00%
- Points to another company24%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Amadeus Capital Partners
Compare Cambridge Innovation Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Cambridge Innovation Capital| Date | Company | Stage |
|---|---|---|
| 5 Nov 2026 | Series B | |
| 16 Oct 2026 | Series C+ | |
| 2 Sept 2026 | Seed | |
| 24 Mar 2026 | Series A | |
| 25 Feb 2026 | Seed Led | |
| 5 Mar 2025 | Seed Led | |
| 19 Feb 2025 | Series C+ | |
| 7 Feb 2025 | Series A |
Round details for Cambridge Innovation Capital
Amounts, full round histories and every co-investor in Cambridge Innovation Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
49 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| ArkVax develops glycoconjugate vaccines for animal health | Healthcare & Biotech | Portfolio page | ||
| Awen Oncology discovers and develops innovative oncology treatments that address the complexities of cancer. | Healthcare & Biotech | Portfolio page | ||
| BeyondMath develops and provides a generative physics engine that uses artificial intelligence to validate and simulate designs | AI & Machine LearningIndustrial & Manufacturing | Feb 2026Seed | Page + round | |
| Bicycle Therapeutics is developing precision-guided therapeutics to target solid tumor cancers and other therapeutic applications | Healthcare & Biotech | Portfolio page | ||
| Cambridge GaN Devices develops and produces gallium nitride transistors and semiconductors | Industrial & Manufacturing | Feb 2025Series C+ | Page + round | |
| Carrick Therapeutics is a clinical-stage biopharmaceutical company focused on building the future of oncological therapy to improve patient outcomes. | Healthcare & Biotech | Portfolio page | ||
| Centessa Pharmaceuticals develops and pursues medicines for patients with various disorders, including sleep-wake, neurological, neurodegenerative and neuropsychiatric disorders. | Healthcare & Biotech | Portfolio page | ||
| CMR Surgical develops and engineers surgical robots, including the Versius Plus, for robotic-assisted surgery. | Healthcare & Biotech | Portfolio page | ||
| The company builds immunotherapies for cancer patients by testing millions of candidates to find the best therapies. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Congenica provides a clinical genomic interpretation platform | Healthcare & Biotech | Portfolio page | ||
| CoSyne Therapeutics uses AI for precision medicine drug discovery | Healthcare & Biotech | Portfolio page | ||
| Cytora streamlines risk intake, triage, and decision-making for insurance companies. | FintechAI & Machine Learning | Portfolio page | ||
| Drishti Discoveries is combining the powers of RNAi therapeutics and gene therapy using a proven, patented artificial microRNA technology to develop a gene therapy for neurodegenerative diseases. | Healthcare & Biotech | Portfolio page | ||
| The company produces a smart menstrual cup that tracks and measures menstrual fluid loss and provides personalized insights on reproductive health. | Healthcare & Biotech | Portfolio page | ||
| Epitopea develops cancer RNA immunotherapies | Healthcare & Biotech | Portfolio page | ||
| ErebaGen activates silent biosynthetic pathways to discover powerful new biocatalysts and chemistry, enabling greener, more efficient routes to the world's most important chemicals. | Industrial & ManufacturingHealthcare & Biotech | Portfolio page | ||
| Forefront RF develops and provides tunable duplexer technology for simplifying radio frequency front-end designs in mobile devices and other wireless systems. | Industrial & ManufacturingConsumer | Portfolio page | ||
| Portfolio page | ||||
| Hothouse Therapeutics transforms plants into sustainable biofactories guided by AI, creating complex molecules beyond the reach of conventional labs. | Healthcare & Biotech | Portfolio page |
About this data
site last read 13 Nov 2026- Site
- cic.vc
- Last read
- 13 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 7 Feb 2025
- Companies checked
- 49
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Cambridge Innovation Capital's profile as data
Pull Cambridge Innovation Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/cic.vc
# also
GET /v1/firms/cic.vc/portfolio
GET /v1/firms/cic.vc/coinvestors
GET /v1/firms/cic.vc/news